Finanzen von Exponent Inc (EXPO)EXPOExponent Inc

Exponent, Inc. (EXPO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Engineering and other scientific, accounting for 85.0% of total sales, equivalent to $141.41M. Another important revenue stream is Environmental and Health. Understanding this composition is critical for investors evaluating how EXPO navigates market cycles within the Business Support Services industry.

Evaluating the bottom line, Exponent, Inc. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 18.82%, while the net margin is 19.75%. These profitability ratios, combined with a Return on Equity (ROE) of 31.20%, provide a clear picture of how effectively EXPO converts its operational activities into shareholder value.

In the context of the broader market, EXPO competes directly with industry leaders such as PRIM and IHS. With a market capitalization of $3.19B, it holds a significant position in the sector. When comparing efficiency, EXPO's gross margin of 100.00% stands against PRIM's 4.88% and IHS's 48.32%. Such benchmarking helps identify whether Exponent, Inc. is trading at a premium or discount relative to its financial performance.

Exponent reported a Q2 2026 revenue of $171.61 million, which is a 20.9% year-over-year increase, and a GAAP EPS of $0.60, exceeding expectations by $0.05. The company has also raised its full-year revenue guidance, reflecting strong operational performance.